These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8819642)

  • 21. Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II.
    Song L; Healy DP
    Hypertension; 1999 Feb; 33(2):746-52. PubMed ID: 10024339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats.
    Britto RR; Santos RA; Fagundes-Moura CR; Khosla MC; Campagnole-Santos MJ
    Hypertension; 1997 Sep; 30(3 Pt 2):549-56. PubMed ID: 9322980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
    Inscho EW; Imig JD; Deichmann PC; Cook AK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced angiotensin II induced sodium appetite in renovascular hypertensive rats.
    Roncari CF; Barbosa RM; Vendramini RC; De Luca LA; Menani JV; Colombari E; Colombari DSA
    Peptides; 2018 Mar; 101():82-88. PubMed ID: 29305157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefical therapeutic effect of Chinese Herbal Xinji'erkang formula on hypertension-induced renal injury in the 2-kidney-1-clip hypertensive rats.
    Huang LL; Pan C; Yu TT; Guo K; Wang XH; Zhang JY; Wang HZ; Gao S
    Afr J Tradit Complement Altern Med; 2014; 11(5):16-27. PubMed ID: 25395699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of angiotensin II-induced blood pressure and structural changes in Fischer 344 and Wistar Kyoto rats.
    Blanc J; Lacolley P; Laurent S; Elghozi JL
    Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):466-73. PubMed ID: 15236636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse model of angiotensin II slow pressor response: role of oxidative stress.
    Kawada N; Imai E; Karber A; Welch WJ; Wilcox CS
    J Am Soc Nephrol; 2002 Dec; 13(12):2860-8. PubMed ID: 12444204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal denervation attenuates long-term hypertensive effects of Angiotensin ii in the rat.
    Hendel MD; Collister JP
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1225-30. PubMed ID: 17184505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pressor responsiveness to angiotensin in renovascular and steroid hypertension.
    Marks ES; Thurston H; Bing RF; Swales JD
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():47s-50s. PubMed ID: 396091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension.
    Buzello M; Boehm C; Orth S; Fischer B; Ehmke H; Ritz E; Mall G; Amann K
    Virchows Arch; 2003 Apr; 442(4):364-71. PubMed ID: 12684765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AT(2) receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension.
    Duke LM; Widdop RE; Kett MM; Evans RG
    Br J Pharmacol; 2005 Feb; 144(4):486-92. PubMed ID: 15678096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced sensitivity of the renal vasculature to angiotensin II in young rats: the role of the angiotensin type 2 receptor.
    Brown RD; Hilliard LM; Mirabito KM; Wirth LC; Moritz KM; Evans RG; Denton KM
    Pediatr Res; 2014 Nov; 76(5):448-52. PubMed ID: 25119338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension.
    Ichihara A; Inscho EW; Imig JD; Michel RE; Navar LG
    Hypertension; 1997 Jan; 29(1 Pt 2):442-9. PubMed ID: 9039140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
    Alánová P; Husková Z; Kopkan L; Sporková A; Jíchová Š; Neckář J; Imig JD; Klevstig M; Kolář F; Rami Reddy N; Falck JR; Sadowski J; Nishiyama A; Kramer HJ; Melenovský V; Červenková L; Kujal P; Vernerová Z; Červenka L
    Vascul Pharmacol; 2015 Oct; 73():45-56. PubMed ID: 26304700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrochlorothiazide improves ventricular compliance and thus performance without reducing hypertrophy in renal artery stenosis in rats.
    Norton GR; Tsotetsi OJ; Woodiwiss AJ
    Hypertension; 1993 May; 21(5):638-45. PubMed ID: 7684025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive and vascular remodelling effects of the imperatorin derivative OW1 in renovascular hypertension rats.
    Zhou N; Wang T; Song J; He H; He J; He L
    Clin Exp Pharmacol Physiol; 2014 Aug; 41(8):571-8. PubMed ID: 24798462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin III and pressor responsiveness in 3-day renal artery stenosis rabbits.
    Johnson JA; Dostal DE; Elsberry-Gonder A
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H540-8. PubMed ID: 2178447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of graded renal artery constriction on blood pressure, renal artery pressure, and plasma renin activity in Goldblatt hypertension.
    Murphy WR; Coleman TG; Smith TL; Stanek KA
    Hypertension; 1984; 6(1):68-74. PubMed ID: 6363282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion.
    Von Thun AM; Vari RC; el-Dahr SS; Navar LG
    Am J Physiol; 1994 Jan; 266(1 Pt 2):F120-8. PubMed ID: 8304477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.